Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Ethanol × Clear all

Phase

Status

Sponsor Class

OTHER 45 NIH 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 857 Carboplatin 804 Paclitaxel 792 Gemcitabine 659 Cisplatin 639 Docetaxel 601 Bevacizumab 534 Nivolumab 425 Pemetrexed 415 Cyclophosphamide 404 Capecitabine 394 Fluorouracil 340 Rituximab 334 Dexamethasone 333 Oxaliplatin 288 Injections 283 atezolizumab 264 Trastuzumab 261 Cetuximab 242 Leucovorin 234 Prednisone 219 Irinotecan 218 130-nm albumin-bound paclitaxel 217 Doxorubicin 210 Ipilimumab 200 Lenalidomide 196 Fulvestrant 188 fludarabine 181 durvalumab 176 Drug Therapy 171

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01698918 2023-05-03

BOLERO-4

Novartis

Phase 2 Completed

202 enrolled 19 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡